https://pressroom.prlog.org/ArjunaTherapeutics/ About Arjuna Therapeutics - We are a new therapeutic platform bringing transformational science to the field of oncology and other disease states. https://www.prlog.org/13136299-arjuna-enters-strategic-collaboration-with-pangaea-oncology-and-the-dr-rosell-oncology-institute.html The research will evaluate Ag5 in treatment-resistant non-small cell lung cancer. Collaboration targets patients who have exhausted Tagrisso® or KRAS inhibitor therapy - an area of critical unmet need with no approved standard of careMon, 30 Mar 2026 13:29:59 GMT https://www.prlog.org/13125772-arjuna-therapeutics-partner-with-oxford-researchers-to-tackle-paediatric-brain-cancer.html Collaboration Carried Out With Support from Brain Research UKThu, 05 Feb 2026 13:22:50 GMT https://www.prlog.org/13070001-new-efficacy-data-for-arjuna-therapeutics-ag5-to-be-presented-at-the-2025-aacr-meeting.html New biomarker and preclinical efficacy data for Ag5 in Glioblastoma Multiforme will be presented at the American Association for Cancer Research (AACR) Annual MeetingFri, 04 Apr 2025 09:35:06 GMT https://www.prlog.org/13021913-arjuna-therapeutics-awarded-prize-at-the-2024-matwin-congress.html ARJUNA Therapeutics is pleased to announce the award of a prize from the MATWIN International Board at the 2024 MATWIN Congress in Bordeaux, France.Thu, 23 May 2024 12:00:10 GMT https://www.prlog.org/12965881-the-phaeo-and-para-cancer-charity-of-the-uk-and-arjuna-therapeutics-announce-their-collaboration.html The Phaeo and Para Cancer Charity of the UK and ARJUNA Therapeutics announce their collaboration to develop treatments for rare tumours driven by mutations in the SDH-B gene.Tue, 23 May 2023 11:51:16 GMT https://www.prlog.org/12956058-arjuna-therapeutics-to-present-at-the-2023-meeting-of-the-american-association-for-cancer-research.html ARJUNA Therapeutics announces that it will be presenting data at the 2023 American Association for Cancer Research meeting in Orlando, Florida, outlining single agent and combinatorial efficacy for its lead asset, Ag5, in Non Small Cell Lung Cancer.Mon, 20 Mar 2023 08:56:37 GMT https://www.prlog.org/12889482-mr-jo-williamson-appointed-as-chief-patient-representative-at-arjuna-therapeutics.html ARJUNA Therapeutics announces the appointment of Mr Jo Williamson as Chief Patient Representative, and advisor to the Scientific Advisory Board (SAB).Thu, 14 Oct 2021 08:47:20 GMT https://www.prlog.org/12865083-arjuna-therapeutics-announces-the-appointment-of-dr-robert-barnes-to-the-board-of-directors.html ARJUNA Therapeutics, the European biotech start-up, announces the appointment of Dr Robert Barnes to the Board of Directors.Thu, 08 Apr 2021 08:35:09 GMT https://www.prlog.org/12863134-arjuna-to-present-data-on-ag5-and-the-tmc-platform-at-aacr-annual-meeting-2021.html London, Santiago de Compostela ARJUNA Therapeutics announced today that data for Arjuna's preclinical Ag5 program will be presented at the American Association of Cancer Research (AACR) 2021 Annual Meeting.Wed, 24 Mar 2021 09:00:00 GMT https://www.prlog.org/12821880-arjuna-therapeutics-announces-the-appointment-of-martin-treder-phd-as-chief-scientific-officer.html ARJUNA Therapeutics announces the appointment of Martin Treder, PhD as Chief Scientific Officer. He will lead the development of ARJUNA's lead assets into clinical development and advance the broad pipeline of TMC compounds. Dr.Mon, 11 May 2020 08:01:19 GMT https://www.prlog.org/12819735-arjuna-therapeutics-named-as-one-of-the-winning-startups-in-position-to-defeat-brain-tumors.html The Center for Advancing Innovation (CAI) announces that ARJUNA Therapeutics is one of the winners of the Brain Race, an open innovation contest to advance high-impact inventions and solutions to defeat brain tumors.Thu, 23 Apr 2020 13:47:46 GMT https://www.prlog.org/12789069-nanogap-therapeutics-relaunched-as-arjuna-therapeutics.html Santiago de Compostela, Spain and St Anselmo, California, USAMon, 16 Sep 2019 06:59:19 GMT